You are here

Real-time bioimpedance based biopsy device

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41CA192502-01A1
Agency Tracking Number: R41CA192502
Amount: $223,942.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: NCI
Solicitation Number: PA13-235
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
779 NH ROUTE 10
ORFORD, NH 03777-4110
United States
DUNS: 78304657
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 (603) 646-0773
Business Contact
Phone: (802) 310-4474
Research Institution
Office of Sponsored Projects 11 Rope Ferry Rd. #6210
HANOVER, NH 03755-1421
United States

 () -
 Nonprofit college or university

DESCRIPTION (provided by applicant): Over the last three decades the number of men diagnosed with prostate cancer has increased 85% as a result of new screening and diagnostic tools. However, a significant number of these newly diagnosed men are harboringclinically insignificant disease, which means that they are not likely to die from prostate cancer. A difficul decision facing urologists daily is determining whether a man with some degree of prostate cancer needs to be treated or not. Currently, men whohave elevated PSA levels or abnormal digital rectal examinations are biopsied to confirm presence of prostate cancer. Unfortunately, typical biopsy protocols sample less than 1% of the entire prostate. As a result, regions of cancer are often entirely missed by biopsy and the small volumes of cancer sampled in other cases do not always provide an accurate assessment of the extent and aggressiveness of the disease. We propose to develop a commercial prototype of a sensor-equipped biopsy needle capable o

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government